বাংলায় দেখুন
Sparlin

Sparlin

Tablet

🧬 Sparfloxacin 🏢 Beximco Pharmaceuticals Ltd.
Generic Name Sparfloxacin
Manufacturer Beximco Pharmaceuticals Ltd.
Unit Price Unit Price: ৳ 15.06 (1 x 10: ৳ 150.60) Strip Price: ৳ 150.60

🔹 Indications

Sparlin is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Sparlin is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Pharmacology

Sparlin is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Sparlin is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Dosage & Administration

Sparlin is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Sparlin is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Interaction

Sparlin is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Sparlin is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Contraindications

Sparlin is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Sparlin is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Side Effects

Sparlin is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Sparlin is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Pregnancy & Lactation

Sparlin is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Sparlin is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Precautions & Warnings

Sparlin is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Sparlin is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

💡 Frequently Asked Questions

Sparlin is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenz...
Sparlin is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenz...
Sparlin is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenz...

User Reviews

No reviews yet!
Be the first to share your experience.

Write a Review